[Overview: Atherogenic lipoproteins and their clinical significance].
Shirai
Kohji
K
Internal Medicine, Sakura Hospital, Toho University.
D001161:Arteriosclerosis / Q000175:diagnosis* / Q000209:etiology*; D015415:Biomarkers / Q000378:metabolism; D002455:Cell Division; D002784:Cholesterol / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D015227:Lipid Peroxidation; D017270:Lipoprotein(a) / Q000502:physiology; D008074:Lipoproteins / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008264:Macrophages / Q000502:physiology; D020782:Matrix Metalloproteinases / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology; D014280:Triglycerides / Q000378:metabolism
D015415:Biomarkers; D008078:Cholesterol, LDL; D016207:Cytokines; D018836:Inflammation Mediators; D017270:Lipoprotein(a); D008074:Lipoproteins; D008077:Lipoproteins, LDL; D014280:Triglycerides; C099252:oxidized low density lipoprotein; C112017:remnant-like particle cholesterol; D002784:Cholesterol; D020782:Matrix Metalloproteinases